Clinical Trial Update: A Clinical Study of SI-B001 in Combination With Paclitaxel in the Treatment of Recurrent and Metastatic HNSCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SI-B001 in combination with Paclitaxel for recurrent/metastatic head and neck squamous cell carcinoma; the study is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• SI-B001

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING